Health
Regeneron suspends COVID-19 antibody trial among sickest patients – Gulf News
Move follows recommendation from independent committee which assesses results
A Regeneron Pharmaceuticals scientist works in the company’s Infectious disease lab in New York state on an experimental coronavirus antibody drug.
Image Credit: Regeneron / via AP file
Washington: US biotech firm Regeneron on Friday said it was suspending enrollment for a study of its COVID-19 antibody treatment among the sickest patients who require high-flow oxygen or are on ventilators.
The move follows a recommendation from an independent data monitoring committee (IDMC) which assesses the…
-
Noosa News20 hours agoRocky waters ahead for Brisbane 2032’s Olympic rowing plan
-
Noosa News18 hours agoMissing man, Maroochydore – Queensland Police News
-
General22 hours agoEV buses join Perth’s wider suburban network, ‘milestone’ for diesel phase-out
-
Noosa News9 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland